Gd-L2: Hepatobiliary MRI Contrast Agent Performance Data

Gd-L2 is a fully alkyl-substituted, chiral gadolinium-based contrast agent designed for magnetic resonance imaging. The dataset, shared by Gengshen Mo on figshare in April 2026, likely contains experimental results on the agent's kinetic inertness, relaxivity, and performance in mouse models of hepatocellular carcinoma. This 301-byte CSV file outlines a nonaromatic molecular engineering strategy for next-generation MRI agents.

Use Cases

• Compare kinetic inertness and relaxivity metrics for different gadolinium-based contrast agent designs.
• Analyze hepatic uptake and renal clearance pathways for targeted MRI agents.
• Evaluate tumor margin delineation performance in orthotopic hepatocellular carcinoma mouse models.

Strengths

• Data describes a novel, dual-site chiral molecular design intended to enhance stability and performance.
• The agent's functionality is validated in a specific biological context: orthotopic hepatocellular carcinoma mouse models.
• Dataset is shared under a clear CC-BY-NC-4.0 license, specifying terms for non-commercial reuse.

Limitations

• Dataset is extremely small at 301 bytes, suggesting it may contain only summary metadata or a minimal table.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for statistical analysis.

Provenance

Source

figshare, authored by Gengshen Mo.

Collection Method

Likely contains synthesized experimental results from molecular engineering and preclinical testing.

Time Range

null

Freshness

Last updated 2026-04-24 15:13:13; freshness should be verified.

Geography

null